Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Point mutations in the presenilin-1 gene (PS1) are a major cause of familial Alzheimer's disease. They result in a selective increase in the production of the amyloidogenic peptide amyloid-beta(1-42) by proteolytic processing of the amyloid precursor protein (APP). Here we investigate whether PS1 is also involved in normal APP processing in neuronal cultures derived from PS1-deficient mouse embryos. Cleavage by alpha- and beta-secretase of the extracellular domain of APP was not affected by the absence of PS1, whereas cleavage by gamma-secretase of the transmembrane domain of APP was prevented, causing carboxyl-terminal fragments of APP to accumulate and a fivefold drop in the production of amyloid peptide. Pulse-chase experiments indicated that PS1 deficiency specifically decreased the turnover of the membrane-associated fragments of APP. As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, PS1 appears to facilitate a proteolytic activity that cleaves the integral membrane domain of APP. Our results indicate that mutations in PS1 that manifest clinically cause a gain of function and that inhibition of PS1 activity is a potential target for anti-amyloidogenic therapy in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is produced by sequential β- and γ-secretase proteolytic cleavage of the amyloid precursor protein (APP) [11–17].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [13]
In the citing paper
“The three major APOE variants, APOE2, APOE3, and APOE4, differ from each other at two amino acid positions, 112 and 158, and modulate AD risk. E3 is the most common APOE variant and is considered neutral with regards to AD risk, while E4 alleles elevate AD risk and E2 reduces AD risk12,13.”
From APOE3 - R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition (2024) · cites this paper as [12]
In the citing paper
“knocking out the gene results in decreased production of both βA4(1-40) and (1-42) amyloid peptides (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“Mutations of presenilin 1 (PS1) causing Alzheimer's disease selectively increase the secretion of the amyloidogenic βA4(1-42)”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“As β- (and α-) clipping was virtually normal in neurons derived from those animals, the effect on APP processing is confined to γ-secretase activities (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · cited 1×
“As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription facto”
BackgroundScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 1×
“This was confirmed using antibodies against amino-acid residues 595–612 (R1736”
MethodAmyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Skeletal and CNS Defects in Presenilin-1-Deficient Mice
Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., & Tonegawa, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80244-5 · Cited by 959
Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm
Wong, P. C., Zheng, H., Chen, H., Becher, M. W., Sirinathsinghji, D. J. S., Trumbauer, M. E., Chen, H. Y., Price, D. L., Van der Ploeg, L. H. T., & Sisodia, S. S. (1997) · Nature · doi:10.1038/387288a0 · Cited by 711
Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
Hartmann, T., Bieger, S. C., Brühl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K., et al. (1997) · Nature Medicine · doi:10.1038/nm0997-1016 · Cited by 709
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
Cited by
Items 101–200 of 1,008
The Presenilins in Alzheimer's Disease--Proteolysis Holds the Key
Haass, C., & Strooper, B. D. (1999) · Science · doi:10.1126/science.286.5441.916 · Cited by 388
Self-citationSun, L., Zhou, R., Yang, G., & Shi, Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618657114 · Cited by 382
“Because PS1 is required for Aβ generation, it was initially suggested that AD-derived mutations might reflect a gain of function (19).”
BackgroundThe epigenetics of aging and neurodegeneration
Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381
“Mutations in the APP gene and the presenilin (PS) genes PS1 and PS2, have been observed in fAD cases (Czech et al., 2000; De Strooper et al., 1998; Goate et al., 1991; Hardy and Higgins, 1992; Migliore and Coppede, 2009; Sherrington et al., 1995; Tanzi et al., 1996).”
BackgroundQing, H., He, G., Ly, P. T. T., Fox, C. J., Staufenbiel, M., Cai, F., Zhang, Z., Wei, S., Sun, X., Chen, C.-H., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081588 · Cited by 364
The Disintegrin/Metalloproteinase ADAM10 Is Essential for the Establishment of the Brain Cortex
Jorissen, E., Prox, J., Bernreuther, C., Weber, S., Schwanbeck, R., Serneels, L., Snellinx, A., Craessaerts, K., Thathiah, A., Tesseur, I., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5221-09.2010 · Cited by 363
“Increased neuronal differentiation in Adam10 cKO brains To assess neuronal differentiation in the Adam10 cKO and control brains, we performed immunostaining for NeuN, a marker for postmitotic neurons, at E12.”
BackgroundMethodSelf-citationSelkoe, D. J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004457 · Cited by 363
“In addition, the production of all Ab peptides is markedly reduced in PS1 knockout embryos because of a loss of g-secretase processing (De Strooper et al. 1998).”
BackgroundSong, W., Nadeau, P., Yuan, M., Yang, X., Shen, J., & Yankner, B. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6959 · Cited by 362
Therapeutic approaches to Alzheimer's disease
Klafki, H.-W., Staufenbiel, M., Kornhuber, J., & Wiltfang, J. (2006) · Brain · doi:10.1093/brain/awl280 · Cited by 362
Uryu, K., Chen, X.-H., Martinez, D., Browne, K. D., Johnson, V. E., Graham, D. I., Lee, V. M.-Y., Trojanowski, J. Q., & Smith, D. H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.018 · Cited by 360
“More specifically, its anabolism is mediated by beta-site APP cleaving enzyme (BACE) and the catalytic component of β-secretase, presenilin-1 (PS1) (De Strooper et al., 1998; Vassar et al., 1999; Nunan and Small, 2000; Selkoe and Wolfe, 2000; Esler and Wolfe, 2001).”
BackgroundEffects of PS1 Deficiency on Membrane Protein Trafficking in Neurons
Naruse, S., Thinakaran, G., Luo, J.-J., Kusiak, J. W., Tomita, T., Iwatsubo, T., Qian, X., Ginty, D. D., Price, D. L., Borchelt, D. R., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80637-6 · Cited by 355
Annaert, W. G., Levesque, L., Craessaerts, K., Dierinck, I., Snellings, G., Westaway, D., George-Hyslop, P. S., Cordell, B., Fraser, P., & De Strooper, B. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.277 · Cited by 353
“The clinical mutations in PS1 do not affect a- and The Journal of Cell Biology, Volume 147, 1999 288 b-secretase activity, complementing the data obtained previously in PS1-deficient neurons (De Strooper et al., 1998).”
InfluentialSelf-citationDe Strooper, B. (2007) · EMBO reports · doi:10.1038/sj.embor.7400897 · Cited by 351
“Presenilin 1—along with the closely related presenilin 2—is the catalytic component of the γ-secretase enzyme, which cleaves the amyloid precursor protein (APP) into Aβs of varying lengths (De Strooper et al, 1998).”
BackgroundBeyond the neuron–cellular interactions early in Alzheimer disease pathogenesis
Henstridge, C. M., Hyman, B. T., & Spires-Jones, T. L. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0113-1 · Cited by 348
Pardossi-Piquard, R., Petit, A., Kawarai, T., Sunyach, C., Alves da Costa, C., Vincent, B., Ring, S., D’Adamio, L., Shen, J., Müller, U., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.04.008 · Cited by 348
Functions and dysfunctions of nitric oxide in brain
Picón-Pagès, P., Garcia-Buendia, J., & Muñoz, F. J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.11.007 · Cited by 347
Three-dimensional structure of human γ-secretase
Lu, P., Bai, X.-C., Ma, D., Xie, T., Yan, C., Sun, L., Yang, G., Zhao, Y., Zhou, R., Scheres, S. H. W., et al. (2014) · Nature · doi:10.1038/nature13567 · Cited by 346
Intramembrane Proteolysis: Theme and Variations
Wolfe, M. S., & Kopan, R. (2004) · Science · doi:10.1126/science.1096187 · Cited by 332
Inhibition of the ubiquitin-proteasome system in Alzheimer's disease
Lam, Y. A., Pickart, C. M., Alban, A., Landon, M., Jamieson, C., Ramage, R., Mayer, R. J., & Layfield, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170173897 · Cited by 324
Sorting through the Cell Biology of Alzheimer's Disease: Intracellular Pathways to Pathogenesis
Small, S. A., & Gandy, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.001 · Cited by 324
Lichtenthaler, S. F., Lemberg, M. K., & Fluhrer, R. (2018) · The EMBO Journal · doi:10.15252/embj.201899456 · Cited by 323
“Initially identified because of its link to APP processing in Alzheimer’s disease (Sherrington et al , 1995; De Strooper et al , 1998; Wolfe et al , 1999), c -secretase currently has more than 100 known substrates (for an overview see Haapasalo & Kovacs, 2011).”
The dysregulation of intracellular calcium in Alzheimer disease
Supnet, C., & Bezprozvanny, I. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.014 · Cited by 323
“Missense mutations in the amyloid precursor protein (APP), the presenilin-1 (PS1) and the presenilin-2 (PS2) genes [22] result in a shift in the proteolysis of APP by the γ-secretase complex such that the ratio of Aβ42/40 protein fragments in the brain is increased [23,24] (Figure 1).”
BackgroundThe mitochondrial serine protease HtrA2/Omi: an overview
Vande Walle, L., Lamkanfi, M., & Vandenabeele, P. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402291 · Cited by 320
Expression Analysis of BACE2 in Brain and Peripheral Tissues
Bennett, B. D., Babu-Khan, S., Loeloff, R., Louis, J.-C., Curran, E., Citron, M., & Vassar, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002688200 · Cited by 317
Mouse models of Alzheimer's disease
Hall, A. M., & Roberson, E. D. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.017 · Cited by 317
Presenilin-Mediated Modulation of Capacitative Calcium Entry
Yoo, A. S., Cheng, I., Chung, S., Grenfell, T. Z., Lee, H., Pack-Chung, E., Handler, M., Shen, J., Xia, W., Tesco, G., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)00066-0 · Cited by 312
“…Rudolph E. Tanzi,* The presenilins appeared to be required for the pro-and Tae-Wan Kim*§ teolytic processing of the amyloid b protein precursor*Genetics and Aging Research Unit (APP) to yield amyloid b peptide (Ab) (i.e., g-secretaseDepartment of Neurology cleavage) (De Strooper et al., 1998).”
Backgroundγ-Secretase in Alzheimer’s disease
Hur, J.-Y. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00754-8 · Cited by 310
“beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.”
BackgroundLiang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K., Caselli, R. J., Kukull, W. A., McKeel, D., Morris, J. C., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00242.2007 · Cited by 309
Dissection of Amyloid-β Precursor Protein-dependent Transcriptional Transactivation
Cao, X., & Südhof, T. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402248200 · Cited by 309
Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
Villegas, S., Roda, A., Serra-Mir, G., Montoliu-Gaya, L., & Tiessler, L. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.332127 · Cited by 306
“In the nonamyloidogenic APP processing, the combined action of α- and γ-secretases releases sAPPα, P3 peptide (which corresponds to the Aβ17–40/42 sequence) and the APP intracellular domain (De Strooper et al., 1998).”
BackgroundSteiner, H., Duff, K., Capell, A., Romig, H., Grim, M. G., Lincoln, S., Hardy, J., Yu, X., Picciano, M., Fechteler, K., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28669 · Cited by 306
Recognition of the amyloid precursor protein by human γ-secretase
Zhou, R., Yang, G., Guo, X., Zhou, Q., Lei, J., & Shi, Y. (2019) · Science · doi:10.1126/science.aaw0930 · Cited by 304
Kwart, D., Gregg, A., Scheckel, C., Murphy, E. A., Paquet, D., Duffield, M., Fak, J., Olsen, O., Darnell, R. B., & Tessier-Lavigne, M. (2019) · Neuron · doi:10.1016/j.neuron.2019.07.010 · Cited by 304
Standardization of measurement of β-amyloid(1-42)in cerebrospinal fluid and plasma
Vanderstichele, H., Kerschaver, E. V., Hesse, C., Davidsson, P., Buyse, M.-A., Andreasen, N., Minthon, L., Wallin, A., Blennow, K., & Vanmechelen, E. (2000) · Amyloid · doi:10.3109/13506120009146438 · Cited by 301
Self-citationTMP21 is a presenilin complex component that modulates γ-secretase but not ɛ-secretase activity
Chen, F., Hasegawa, H., Schmitt-Ulms, G., Kawarai, T., Bohm, C., Katayama, T., Gu, Y., Sanjo, N., Glista, M., Rogaeva, E., et al. (2006) · Nature · doi:10.1038/nature04667 · Cited by 301
Calcium ions in neuronal degeneration
Wojda, U., Salinska, E., & Kuznicki, J. (2008) · IUBMB Life · doi:10.1002/iub.91 · Cited by 301
“In FAD pathogenesis, the generation of toxic Ab from mutant APP creates an intense stress leading to an accelerated Ca21 dyshomeostasis, as described above.”
BackgroundInfluentialPresenilin-1 and -2 Are Molecular Targets for γ-Secretase Inhibitors
Seiffert, D., Bradley, J. D., Rominger, C. M., Rominger, D. H., Yang, F., Meredith, J. E., Wang, Q., Roach, A. H., Thompson, L. A., Spitz, S. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005430200 · Cited by 301
Wunderlich, P., Glebov, K., Kemmerling, N., Tien, N. T., Neumann, H., & Walter, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517540 · Cited by 296
“-Secretase cleaves the amyloid precursor protein and thus, plays a direct role in amyloid- generation (34, 35).”
BackgroundDeciphering the Genetic Basis of Alzheimer's Disease
Selkoe, D. J., & Podlisny, M. B. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103022 · Cited by 294
“There is a corresponding substantial decrease (∼70%) in the production of both Aß40 and Aß42 (29).”
BackgroundResultInfluentialAlzheimer’s disease: pathological mechanisms and the beneficial role of melatonin
Rosales‐Corral, S. A., Acuña‐Castroviejo, D., Coto‐Montes, A., Boga, J. A., Manchester, L. C., Fuentes‐Broto, L., Korkmaz, A., Ma, S., Tan, D. X., & Reiter, R. J. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00937.x · Cited by 294
“Then, C99 is cleaved from the membrane by the c-secretase, a multisubunit protease complex composed of a presenilin catalytic subunit in addition to nicastrin, the anterior pharynx-defective 1 (APH-1), and the presenilin enhancer 2 (PEN-2) [120, 121].”
BackgroundUpdate on hypertension and Alzheimer's disease
Skoog, I., & Gustafson, D. (2006) · Neurological Research · doi:10.1179/016164106x130506 · Cited by 294
Buxbaum, J. D., Thinakaran, G., Koliatsos, V., O’Callahan, J., Slunt, H. H., Price, D. L., & Sisodia, S. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09629.1998 · Cited by 293
Genetic insights in Alzheimer's disease
Bettens, K., Sleegers, K., & Van Broeckhoven, C. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70259-4 · Cited by 290
Wnt signaling function in Alzheimer’s disease
De Ferrari and, G. V., & Inestrosa, N. C. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00021-7 · Cited by 289
Induction of neuronal death by ER stress in Alzheimer’s disease
Katayama, T., Imaizumi, K., Manabe, T., Hitomi, J., Kudo, T., & Tohyama, M. (2004) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.12.004 · Cited by 287
Presenilin-dependent γ-Secretase-like Intramembrane Cleavage of ErbB4
Lee, H.-J., Jung, K.-M., Huang, Y. Z., Bennett, L. B., Lee, J. S., Mei, L., & Kim, T.-W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110371200 · Cited by 286
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Cao, J., Hou, J., Ping, J., & Cai, D. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0299-8 · Cited by 285
Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M., & Haass, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200469200 · Cited by 280
Dawkins, E., & Small, D. H. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12675 · Cited by 279
“…consisting minimally of four protein subunits, presenilin 1 or 2, nicastrin, anterior pharynxdefective phenotype and presenilin enhancer 2 (De Strooper et al. 1998; Yu et al. 2000; Francis et al. 2002; Kimberly et al. 2003). c-Secretase cleavage is a type of regulated intramembrane…”
BackgroundIntegration of endoplasmic reticulum signaling in health and disease
Aridor, M., & Balch, W. E. (1999) · Nature Medicine · doi:10.1038/10466 · Cited by 279
Lessons from a failed γ-secretase Alzheimer trial
De Strooper, B. (2014) · Cell · doi:10.1016/j.cell.2014.10.016 · Cited by 277
Beal, M. F. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041772.74810.92 · Cited by 277
Niwa, M., Sidrauski, C., Kaufman, R. J., & Walter, P. (1999) · Cell · doi:10.1016/s0092-8674(00)81667-0 · Cited by 276
Karran, E., & Hardy, J. (2014) · Annals of Neurology · doi:10.1002/ana.24188 · Cited by 275
Götz, J., Streffer, J. R., David, D., Schild, A., Hoerndli, F., Pennanen, L., Kurosinski, P., & Chen, F. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001508 · Cited by 274
A physiologic signaling role for the γ-secretase-derived intracellular fragment of APP
Leissring, M. A., Murphy, M. P., Mead, T. R., Akbari, Y., Sugarman, M. C., Jannatipour, M., Anliker, B., Müller, U., Saftig, P., De Strooper, B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072033799 · Cited by 273
A Furin-like Convertase Mediates Propeptide Cleavage of BACE, the Alzheimer's β-Secretase
Bennett, B. D., Denis, P., Haniu, M., Teplow, D. B., Kahn, S., Louis, J.-C., Citron, M., & Vassar, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005339200 · Cited by 273
Chen, X.-H., Siman, R., Iwata, A., Meaney, D. F., Trojanowski, J. Q., & Smith, D. H. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63303-2 · Cited by 271
Wiltfang, J., Esselmann, H., Bibl, M., Smirnov, A., Otto, M., Paul, S., Schmidt, B., Klafki, H. ‐., Maler, M., Dyrks, T., et al. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00818.x · Cited by 271
Ding, Y., Qiao, A., Wang, Z., Goodwin, J. S., Lee, E.-S., Block, M. L., Allsbrook, M., McDonald, M. P., & Fan, G.-H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3153-08.2008 · Cited by 269
“…by successive proteolysis of -amyloid precursor protein (APP), a large transmembrane glycoprotein that is initially cleaved by the -site APPcleaving enzyme 1 (BACE1) and subsequently by -secretase in the transmembrane domain (De Strooper et al., 1998; Vassar et al., 1999; Edbauer et al., 2003).”
BackgroundThe Emerging Link between O-GlcNAc and Alzheimer Disease
Zhu, Y., Shan, X., Yuzwa, S. A., & Vocadlo, D. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.601351 · Cited by 267
“APP is cleaved by -secretase (87) and -secretase (88), as well as by the -secretase complex (89) (Fig.”
BackgroundThe Production of Amyloid β Peptide Is a Critical Requirement for the Viability of Central Neurons
Plant, L. D., Boyle, J. P., Smith, I. F., Peers, C., & Pearson, H. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05531.2003 · Cited by 266
“Knock - out of PS1 alone does not have a toxic effect , although A production is reduced by 80% in cells cultured from such animals ( De Strooper et al .”
BackgroundCell Surface Presenilin-1 Participates in the γ-Secretase-like Proteolysis of Notch
Ray, W. J., Yao, M., Mumm, J., Schroeter, E. H., Saftig, P., Wolfe, M., Selkoe, D. J., Kopan, R., & Goate, A. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36801 · Cited by 266
CADASIL: a Common Form of Hereditary Arteriopathy Causing Brain Infarcts and Dementia
Kalimo, H., Ruchoux, M., Viitanen, M., & Kalaria, R. N. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00451.x · Cited by 266
“Figure 6) (14, 15, 63), mutations of presenilin-1 being the major cause of early onset familial AD SYMPOSIUM: Pathogenesis of Non-atherosclerotic Cerebrovascular Disease”
BackgroundMolecular genetics of Alzheimer’s disease
St George-Hyslop, P. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00301-7 · Cited by 265
Physiology and Pathology of Calcium Signaling in the Brain
Kawamoto, E. M., Vivar, C., & Camandola, S. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00061 · Cited by 249
“…1, and presenilin enhancer 2, translocate to the plasma membrane where they function as the γ-secretase enzyme responsible of the amyloid precursor protein (APP) cleavage generating amyloid β, the primary component of amyloid plaques in AD (De Strooper et al., 1998; De Strooper and Annaert, 2010).”
BackgroundFilamentous nerve cell inclusions in neurodegenerative diseases
Goedert, M., Spillantini, M. G., & Davies, S. W. (1998) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(98)80090-1 · Cited by 262
Steiner, H., Kostka, M., Romig, H., Basset, G., Pesold, B., Hardy, J., Capell, A., Meyn, L., Grim, M. L., Baumeister, R., et al. (2000) · Nature Cell Biology · doi:10.1038/35041097 · Cited by 261
γ-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer’s Disease
Serneels, L., Van Biervliet, J., Craessaerts, K., Dejaegere, T., Horré, K., Van Houtvin, T., Esselmann, H., Paul, S., Schäfer, M. K., Berezovska, O., et al. (2009) · Science · doi:10.1126/science.1171176 · Cited by 260
Self-citationModels of β-amyloid induced Tau-pathology: The long and “folded” road to understand the mechanism
Stancu, I.-C., Vasconcelos, B., Terwel, D., & Dewachter, I. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-51 · Cited by 256
“Identification of alpha-secretase (ADAM10 [10], TACE), beta-secretase (BACE1 [11]) and gamma-secretase (as a complex containing aph1, pen2, nicastrin, PS1 [12,13]) and the analysis of their potential as therapeutic targets”
BackgroundSeabrook, G. R., Smith, D. W., Bowery, B. J., Easter, A., Reynolds, T., Fitzjohn, S. M., Morton, R. A., Zheng, H., Dawson, G. R., Sirinathsinghji, D. J. S., et al. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00204-4 · Cited by 256
Larner, A. J., & Doran, M. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0019-5 · Cited by 256
“Brain cultures from presenilin-1 knockout mouse embryos (knockout mice die shortly after birth) showed marked suppression of γ-secretase activity [40].”
APP Processing and Synaptic Plasticity in Presenilin-1 Conditional Knockout Mice
Yu, H., Saura, C. A., Choi, S.-Y., Sun, L. D., Yang, X., Handler, M., Kawarabayashi, T., Younkin, L., Fedeles, B., Wilson, M. A., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00417-2 · Cited by 256
“The generationBogdan Fedeles,4 Matthew A. Wilson,4 of A peptides is markedly reduced in cultured PS1 / Steve Younkin,5 Eric R. Kandel,6 neurons (De Strooper et al., 1998).”
BackgroundResultThe Notch ligand Delta1 is sequentially cleaved by an ADAM protease and γ-secretase
Six, E., Ndiaye, D., Laâbi, Y., Brou, C., Gupta-Rossi, N., Israël, A., & Logeat, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1230693100 · Cited by 250
Kimberly, W. T., Xia, W., Rahmati, T., Wolfe, M. S., & Selkoe, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3173 · Cited by 253
Yuzwa, S. A., & Vocadlo, D. J. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00038b · Cited by 247
Novel Research Horizons for Presenilins and γ-Secretases in Cell Biology and Disease
De Strooper, B., & Annaert, W. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100109-104117 · Cited by 234
Self-citationAlzheimer’s-Causing Mutations Shift Aβ Length by Destabilizing γ-Secretase-Aβn Interactions
Szaruga, M., Munteanu, B., Lismont, S., Veugelen, S., Horré, K., Mercken, M., Saido, T. C., Ryan, N. S., De Vos, T., Savvides, S. N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.004 · Cited by 248
Pruessmeyer, J., & Ludwig, A. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.09.005 · Cited by 234
Membrane rafts in Alzheimer's disease beta-amyloid production
Vetrivel, K. S., & Thinakaran, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.03.007 · Cited by 247
Structural basis of Notch recognition by human γ-secretase
Yang, G., Zhou, R., Zhou, Q., Guo, X., Yan, C., Ke, M., Lei, J., & Shi, Y. (2019) · Nature · doi:10.1038/s41586-018-0813-8 · Cited by 238
Ghosal, K., Vogt, D. L., Liang, M., Shen, Y., Lamb, B. T., & Pimplikar, S. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907652106 · Cited by 245
“Generation of A peptides is obligatorily coupled to that of AICD; both result from the cleavage by presenilin and the loss of presenilin gene function abolishes the production of both (16).”
BackgroundOffe, K., Dodson, S. E., Shoemaker, J. T., Fritz, J. J., Gearing, M., Levey, A. I., & Lah, J. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4946-05.2006 · Cited by 245
“The third secretase activity, -secretase, responsible for the final cleavage that releases A , is mediated by a large multiprotein complex, which includes presenilin-1 (De Strooper et al., 1998; Wolfe et al., 1999) (for review, see Iwatsubo, 2004).”
BackgroundGrbovic, O. M., Mathews, P. M., Jiang, Y., Schmidt, S. D., Dinakar, R., Summers-Terio, N. B., Ceresa, B. P., Nixon, R. A., & Cataldo, A. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304122200 · Cited by 236
Runz, H., Rietdorf, J., Tomic, I., de Bernard, M., Beyreuther, K., Pepperkok, R., & Hartmann, T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01679.2002 · Cited by 242
“We deter- mined the effects of intracellular cholesterol distribution on PS localization and APP cleavage by two means, first by using compounds that inhibit cholesterol transport from endocytic compartments to the ER and second by examining cells expressing mutant”
MethodMolecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics
Masters, C. L., Cappai, R., Barnham, K. J., & Villemagne, V. L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03989.x · Cited by 241
“Gene deletion of presenilin 1 shows that it is indispensable for the generation of Ab (De Strooper et al. 1998).”
BackgroundCupers, P., Orlans, I., Craessaerts, K., Annaert, W., & De Strooper, B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00516.x · Cited by 234
“…involves cleavage of a peptide bond in the hydrophobic environment of the phospholipid membrane, and depends critically on the presenilins (De Strooper et al. 1998; Naruse et al. 1998; Song et al. 1999; Wolfe et al. 1999; Esler et al. 2000; Herreman et al. 2000; Li et al. 2000; Zhang et al.…”
BackgroundInfluentialSelf-citationPresenilins mediate a dual intramembranous gamma-secretase cleavage of Notch-1
Okochi, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf541 · Cited by 229
“…proteins have been identi®ed as substrates for PS-dependent endoproteolysis, including the Alzheimer's disease (AD)-associated b-amyloid protein precursor (bAPP) (De Strooper et al., 1998), ErbB-4 (Ni et al., 2001; Lee et al., 2002), E-cadherin (Marambaud et al., 2002) and LRP (May et al., 2002).”
BackgroundLoss of presenilin 1 is associated with enhanced β-catenin signaling and skin tumorigenesis
Xia, X., Qian, S., Soriano, S., Wu, Y., Fletcher, A. M., Wang, X.-J., Koo, E. H., Wu, X., & Zheng, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191284198 · Cited by 236
Genetically engineered mouse models of neurodegenerative diseases
Wong, P. C., Cai, H., Borchelt, D. R., & Price, D. L. (2002) · Nature Neuroscience · doi:10.1038/nn0702-633 · Cited by 234
PEN-2 and APH-1 Coordinately Regulate Proteolytic Processing of Presenilin 1
Luo, W.-J., Wang, H., Li, H., Kim, B. S., Shah, S., Lee, H.-J., Thinakaran, G., Kim, T.-W., Yu, G., & Xu, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200648200 · Cited by 229
Dewachter, I., Reversé, D., Caluwaerts, N., Ris, L., Kuipéri, C., Van den Haute, C., Spittaels, K., Umans, L., Serneels, L., Thiry, E., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03445.2002 · Cited by 237
“Subsequently, and opposite to the monotonous decrease in APP[V717I] transgenic mice, the slope of fEPSP increased progressively in sections of PS1(n / ) transgenic mice to attain a mean level that approached that of wild-type mice 2 hr after the tetanic stimulus (Fig.”
BackgroundInfluentialNeurogenesis in aging and age-related neurodegenerative diseases
Culig, L., Chu, X., & Bohr, V. A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101636 · Cited by 218
Verret, L., Jankowsky, J. L., Xu, G. M., Borchelt, D. R., & Rampon, C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5564-06.2007 · Cited by 226
“Presenilins are mainly known as the catalytic subunits of -secretase (De Strooper et al., 1998; Haass and De Strooper, 1999; Wolfe et al., 1999), and PS1 mutations associated with AD clearly retain this function.”
BackgroundLichtenthaler, S. F., Wang, R., Grimm, H., Uljon, S. N., Masters, C. L., & Beyreuther, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3053 · Cited by 234
Cai, J., Jiang, W. G., Grant, M. B., & Boulton, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507401200 · Cited by 235
RetractedDeciphering the genesis and fate of amyloid β-protein yields novel therapies for Alzheimer disease
Selkoe, D. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16783 · Cited by 204
Marzi, S. J., Leung, S. K., Ribarska, T., Hannon, E., Smith, A. R., Pishva, E., Poschmann, J., Moore, K., Troakes, C., Al-Sarraj, S., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0253-7 · Cited by 232
Kitazume, S., Tachida, Y., Oka, R., Shirotani, K., Saido, T. C., & Hashimoto, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241509198 · Cited by 232
Familial Alzheimer disease–linked mutations specifically disrupt Ca2+ leak function of presenilin 1
Nelson, O., Tu, H., Lei, T., Bentahir, M., de Strooper, B., & Bezprozvanny, I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30447 · Cited by 226
“Consistent with the role of presenilins as catalytic subunits of γ-secretase (6, 7), FAD mutations in presenilins affect APP processing.”
BackgroundDe Jonghe, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.16.1665 · Cited by 223
Self-citation
Metadata
- Authors
- De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- University of Göttingen (DE)
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6665
- Pages
- 387-390
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1655404681
- Cited by
- 1,818
- References
- 30
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 47 · 2023: 42 · 2022: 33 · 2021: 35 · 2020: 53 · 2019: 43 · 2018: 36 · 2017: 58 · 2016: 60 · 2015: 43 · 2014: 55 · 2013: 64 · 2012: 71
- FWCI
- 76.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- presenilin 1, amyloid precursor protein, APP processing, gamma-secretase, amyloid-beta 42, Alzheimer's disease, familial Alzheimer's disease, carboxyl-terminal fragment, gain-of-function, membrane proteolysis
- MeSH terms
- Animals, Cells, Cultured, Humans, Membrane Proteins, Neurons, Peptide Fragments, Endopeptidases, Protein Processing, Post-Translational, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Point Mutation, Mice, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.